Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3440
Gene Symbol: IFNA2
IFNA2 		0.300 Biomarker phenotype CTD_human Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection. 15951019 2006
Entrez Id: 4549
Gene Symbol: RNR1
RNR1 		0.300 Biomarker phenotype CTD_human A novel mitochondrial mutation, 1556C --> T, in a Japanese patient with streptomycin-induced tinnitus. 15141753 2004
Entrez Id: 627
Gene Symbol: BDNF
BDNF 		0.220 Biomarker phenotype BEFREE In this case-control study, we examined the possible effects of BDNF/GDNF methylations in the blood samples of patients with tinnitus complaints for more than 3 months. 31041673 2019
Entrez Id: 627
Gene Symbol: BDNF
BDNF 		0.220 GeneticVariation phenotype BEFREE In this study, we examined the possible effects of BDNF variants in individuals diagnosed with tinnitus for more than 3 months. 28615544 2017
Entrez Id: 627
Gene Symbol: BDNF
BDNF 		0.220 Biomarker phenotype RGD Local application of the GABA(A) receptor modulator midazolam resulted in the reversal not only of salicylate-induced changes in cochlear BDNF expression, but also in cortical Arg3.1 expression, indicating that the tinnitus-associated changes in cochlear BDNF expression trigger the decline of cortical Arg3.1 expression. 18524887 2008
Entrez Id: 23237
Gene Symbol: ARC
ARC 		0.200 Biomarker phenotype RGD Midazolam reverses salicylate-induced changes in brain-derived neurotrophic factor and arg3.1 expression: implications for tinnitus perception and auditory plasticity. 18524887 2008
Entrez Id: 18
Gene Symbol: ABAT
ABAT 		0.200 Therapeutic phenotype RGD Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model. 17221143 2007
Entrez Id: 1690
Gene Symbol: COCH
COCH 		0.110 GeneticVariation phenotype BEFREE Novel COCH mutation in a family with autosomal dominant late onset sensorineural hearing impairment and tinnitus. 23374487 2013
Entrez Id: 1188
Gene Symbol: CLCNKB
CLCNKB 		0.110 GeneticVariation phenotype BEFREE To explore the impact of ClC-Kb(T481S) on hearing, healthy volunteers (n=329) and individuals suffering from tinnitus (n=246) volunteered for hearing tests (n=348) and genetic analysis (n=575). 16549283 2006
Entrez Id: 1690
Gene Symbol: COCH
COCH 		0.110 Biomarker phenotype HPO
Entrez Id: 1188
Gene Symbol: CLCNKB
CLCNKB 		0.110 Biomarker phenotype HPO
Entrez Id: 84617
Gene Symbol: TUBB6
TUBB6 		0.100 CausalMutation phenotype CLINVAR Missense mutations in the AFG3L2 proteolytic domain account for ∼1.5% of European autosomal dominant cerebellar ataxias. 20725928 2010
Entrez Id: 10939
Gene Symbol: AFG3L2
AFG3L2 		0.100 CausalMutation phenotype CLINVAR Missense mutations in the AFG3L2 proteolytic domain account for ∼1.5% of European autosomal dominant cerebellar ataxias. 20725928 2010
Entrez Id: 23516
Gene Symbol: SLC39A14
SLC39A14 		0.100 Biomarker phenotype HPO
Entrez Id: 4358
Gene Symbol: MPV17
MPV17 		0.100 CausalMutation phenotype CLINVAR
Entrez Id: 4668
Gene Symbol: NAGA
NAGA 		0.100 Biomarker phenotype HPO
Entrez Id: 4358
Gene Symbol: MPV17
MPV17 		0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 6391
Gene Symbol: SDHC
SDHC 		0.100 Biomarker phenotype HPO
Entrez Id: 56616
Gene Symbol: DIABLO
DIABLO 		0.100 Biomarker phenotype HPO
Entrez Id: 9927
Gene Symbol: MFN2
MFN2 		0.100 Biomarker phenotype HPO
Entrez Id: 29888
Gene Symbol: STRN4
STRN4 		0.100 CausalMutation phenotype CLINVAR
Entrez Id: 5155
Gene Symbol: PDGFB
PDGFB 		0.100 Biomarker phenotype HPO
Entrez Id: 3762
Gene Symbol: KCNJ5
KCNJ5 		0.100 Biomarker phenotype HPO
Entrez Id: 595
Gene Symbol: CCND1
CCND1 		0.100 Biomarker phenotype HPO
Entrez Id: 80736
Gene Symbol: SLC44A4
SLC44A4 		0.100 Biomarker phenotype HPO